Literature DB >> 9188388

Effect of use of vasopressors in organ donors on immediate function of renal allografts.

E A O'Brien1, S A Bour, R L Marshall, N Ahsan, H C Yang.   

Abstract

The purpose of this study was to determine whether use of vasopressors in cadaveric donors of renal transplants was associated with an increased prevalence of acute tubular necrosis after kidney transplantation. We compared immediate allograft function in 26 consecutive renal allograft recipients whose donors had been given vasopressors with that in 26 recipients whose donors had nor. The donors treated with vasopressors had been given more than 10 micrograms/kg per minute of dopamine, norepinephrine, or epinephrine, alone or in combination. The groups were matched with respect to donors' age, recipients' disease, and cold ischemic time. The prevalence of immediate allograft function was significantly lower in recipients whose donors had required use of vasopressors (38.5%) than in recipients whose donors had not required vasopressors (65.4%). We conclude that use of vasopressors in kidney donors leads to an increased prevalence of acute tubular necrosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9188388     DOI: 10.7182/prtr.1.6.4.e1g711321k55563r

Source DB:  PubMed          Journal:  J Transpl Coord        ISSN: 0905-9199


  2 in total

1.  Impact of the use of vasoactive drugs in cardiac death donors on the early postoperative renal function and related complications in renal transplant recipients.

Authors:  Peng Zhang; Peihua Cao; Jiali Fang; Guanghui Li; Lei Zhang; Lu Xu; Shijing Mo; Xingqiang Lai; Luhao Liu; Yunyi Xiong; Wei Yin; Li Li; Rongxin Chen; Hailin Xu; Tao Zhang; Jiao Wan; Yuhe Guo; Junjie Ma; Zheng Chen
Journal:  Ann Transl Med       Date:  2020-02

2.  Interest of low-dose hydrocortisone therapy during brain-dead organ donor resuscitation: the CORTICOME study.

Authors:  Michel Pinsard; Stéphanie Ragot; Paul Michel Mertes; Jean Paul Bleichner; Samira Zitouni; Fabrice Cook; Marc Pierrot; Laurent Dube; Edgard Menguy; Laurent Martin Lefèvre; Laurence Escaravage; Pierre-François Dequin; Philippe Vignon; Nicolas Pichon
Journal:  Crit Care       Date:  2014-07-23       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.